iSOFT Expands in Russia after Agreement with ML Park

iSOFTiSOFT Deutschland has strengthened its position in Russia's healthcare market after a partnership agreement with ML Park of Moscow to distribute and support iSOFT's laboratory information systems (LIS). The market in Russia offers huge potential and is set to grow at unprecedented rates. The Russian market for medical technology is worth US$2 billion a year and is growing by about 15 per cent per annum. The 'National Health Programme', which was initiated by president Putin (until 2010) provides US$1.7 billion to build 15 specialised health centres.

iSOFT has already installed its LabCentre laboratory system at KDL Test, a private laboratory chain with laboratories in Moscow, Omsk, Perm and Krasnodar. ML Park and KDL Test are sister companies and both are subsidiaries of ML Group.

iSOFT Deutschland, part of the IBA Health Group – the world's fourth largest healthcare IT provider – will focus on providing modern laboratory software solutions in Russia. Peter Herrmann, Managing Director, iSOFT Deutschland, said: "Through our partnership with ML Park we can support our Russian laboratory customers locally and develop systems to meet local needs. An early presence in this booming healthcare market is absolutely necessary. For us, this will be the basis for more efficient market cultivation and a fast and wide market penetration with our solutions.

ML Park's knowledge of laboratory systems and the private LIS market in Russia will be invaluable in establishing a support organisation in Russia."

Core elements of the agreement are the distribution, implementation and support of the leading iSOFT laboratory solution, LabCentre. iSOFT is the market leader in laboratory information systems with more than 270 installations in Germany, Switzerland, Austria, Russia and Malaysia. LabCentre is a full-graphic integrated system, covering clinical laboratory, blood donation and microbiology.

Related news articles:

About iSOFT
Following a merger completed on Tuesday 30 October, iSOFT is now part of the IBA Health Group. For further information, please visit http://www.ibahealth.com.

iSOFT products are used by more than 8,000 organisations in 27 countries for managing patient information and driving improvements in healthcare services. For further information, please visit http://www.isoftplc.com.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...